Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin-resistant enterococci

B E Murray1

  • 1Department of Internal Medicine, University of Texas Medical School, Houston 77030, USA.

The American Journal of Medicine
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis.

Antimicrobial agents and chemotherapy·2014
Same author

Intramuscular and subcutaneous lipid fatty acid profile composition in male and female foals.

Meat science·2011
Same author

The effect of cooking on the fatty acid composition of longissimus muscle from beef heifers fed rations designed to increase the concentration of conjugated linoleic acid in tissue.

Meat science·2011
Same author

Application of molecular techniques to the study of nosocomial infections caused by enterococci.

Methods in molecular medicine·2011
Same author

Management of multidrug-resistant enterococcal infections.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2010
Same author

Nosocomial outbreak of Enteroccocus gallinarum: untaming of rare species of enterococci.

The Journal of hospital infection·2008
Same journal

Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

The American journal of medicine·2026
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric panniculitis.

The American journal of medicine·2026
See all related articles

Enterococci cause serious hospital infections and endocarditis. Acquired vancomycin resistance in enterococci, often combined with ampicillin resistance, poses a significant therapeutic challenge and risk for untreatable infections.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Enterococci are a significant cause of nosocomial infections and endocarditis.
  • These bacteria are known for developing multiple antibiotic resistance traits.
  • The emergence of vancomycin-resistant enterococci (VRE) presents a critical clinical challenge.

Purpose of the Study:

  • To highlight the growing problem of antibiotic resistance in enterococci.
  • To emphasize the therapeutic implications of vancomycin and ampicillin resistance in enterococci.
  • To underscore the potential for transfer of resistance genes to other pathogens.

Main Methods:

  • Review of clinical observations and microbiological data regarding enterococcal infections.
  • Analysis of antibiotic resistance patterns, particularly vancomycin and ampicillin resistance.

Related Experiment Videos

  • Assessment of the implications of transferable resistance mechanisms.

    • Main Results:

    • Enterococci have been a major cause of hospital-acquired infections for two decades.
    • Acquired vancomycin resistance, especially in ampicillin-resistant strains, severely limits treatment options.
    • Vancomycin resistance can be transferred to other Gram-positive organisms.

    Conclusions:

    • Vancomycin-resistant enterococci (VRE) represent a serious threat due to limited therapeutic alternatives.
    • The combination of vancomycin and ampicillin resistance in enterococci has devastating consequences.
    • The potential for widespread untreatable infections due to transferable resistance is a significant public health concern.